AARD — Aardvark Therapeutics Cashflow Statement
0.000.00%
Last trade - 00:00Annual cashflow statement for Aardvark Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K |
| Standards: | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final |
| Net Income/Starting Line | -13.6 | -7.21 | -20.6 | -57.6 |
| Depreciation | ||||
| Non-Cash Items | 4.33 | 1.47 | 0.912 | 3.03 |
| Unusual Items | ||||
| Other Non-Cash Items | ||||
| Changes in Working Capital | -1.31 | -0.081 | 1.57 | 0.356 |
| Change in Prepaid Expenses | ||||
| Change in Accounts Payable | ||||
| Change in Accrued Expenses | ||||
| Cash from Operating Activities | -10.5 | -5.82 | -18.1 | -54.2 |
| Capital Expenditures | — | — | -0.109 | -0.095 |
| Purchase of Fixed Assets | ||||
| Other Investing Cash Flow Items | -1 | 0 | -11.9 | -49.6 |
| Sale/Maturity of Investment | ||||
| Purchase of Investments | ||||
| Other Investing Cash Flow | ||||
| Cash from Investing Activities | -1 | 0 | -12 | -49.7 |
| Financing Cash Flow Items | — | — | -3.34 | -2.39 |
| Other Financing Cash Flow | ||||
| Net Issuance / Retirement of Stock | ||||
| Cash from Financing Activities | 0.225 | 0 | 82 | 89.2 |
| Beginning Cash Balance | ||||
| Ending Cash Balance | ||||
| Net Change in Cash | -11.3 | -5.82 | 51.9 | -14.6 |